Arix Bioscience, Amryt Pharma and Paul Hill on 5 Stocks to Follow
Episode 2141, Nov 06, 2020, 01:25 PM
Arix Bioscience: Merck acquires their investee co VelosBio for $2.75b. Amryt Pharma: Record Q3 Results & raised FY 2020 revenue guidance.Paul Hill on Astrazeneca, GSK, SourceBio International, Verici DX, Gattaca & Proactis Holdings.
On the Vox Markets Podcast Today: 6th November 2020
Jonathan Tobin, Managing Director at Arix Bioscience #ARIX and VelosBio Board Director discusses Merck's $2.75 billion acquisition of VelosBio.
Joe Wiley, CEO of Amryt Pharma #AMYT talks about their record Q3 Results where they've raised FY 2020 revenue guidance.
(Interview starts at 11 minutes 13 seconds)
Paul Hill, full time investor and equity analyst talks about 5 stock to add to your watchlist including: Astrazeneca #AZN GSK #GSK Mpac Group #MPAC SourceBio International #SBI Verici DX #VRCI Gattaca #GATC & Proactis Holdings #PHD
(Interview starts at 24 minutes 10 seconds)
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast